SZSE Ticker: 002675

Yantai Dongcheng Biochemicals Co., Ltd.

烟台东诚药业集团股份有限公司

东诚药业

DONGCHENG BIOCHEM

Listing Date: 2012-05-25

Board: SME

Industry Classification: Manufacturing

Qianjinsu is a new drug for the new crown? Bio Valley soared by 68% in two days, Qianjin Pharmaceutical and others continued to daily limit Bio Valley – yqqlm

Qianjinsu is a new drug for the new crown? Bio Valley soared by 68% in two days, Qianjin Pharmaceutical and others continued to daily limit Bio Valley – yqqlm

What are the concept stocks in the industry chain? -Stock Channel-Hexun.com

The pharmaceutical and biological industry has a net outflow of 2.855 billion yuan today, and the net outflow of 6 shares exceeds 100 million yuan.

The biomedical sector rose 0.25%, and Hepuri rose 10.03% to top the list – yqqlm

Before and after May 1st, the chairman of 4 companies resigned, and the resignation of 14 directors, supervisors and senior executives was due to "personal reasons".

45 stocks received institutional buy ratings today, 12 stocks rose more than 20%_Oriental Fortune Network

Investment hedging guide: The coordinated procurement of 3 types of medical consumables in Beijing-Tianjin-Hebei will be implemented on May 1. The net profit of Jinshan Office in the first quarter decreased by 18.42% year-on-year, and Dongxing Securities decreased by 87.97% in the first quarter.

Dongcheng Pharmaceutical: Mr. Lv Chunxiang applied to resign from the position of employee representative supervisor of the company due to the change of position.

Dongcheng Pharmaceutical: The board of directors agreed to appoint Lv Chunxiang as the company's deputy general manager.

Dongcheng Pharmaceutical: Net profit in the first quarter of 2022 is about 54.92 million yuan, down 17.9% year-on-year

Dongcheng Pharmaceutical: As of the date of this announcement, the cumulative guarantee amount of the company and its controlled subsidiaries is approximately RMB 1.648 billion per net

Dongcheng Pharmaceutical: On April 26, the net repayment of financing was 9.5754 million yuan, and the net repayment on the previous trading day was 6.1974 million yuan

Announcement Essence and Trading Tips

Dongcheng Pharmaceutical's application for non-public offering of shares was approved by the China Securities Regulatory Commission

Dongcheng Pharmaceutical: The company is currently developing 3 heparin products

Dongcheng Pharmaceutical: The company is currently developing 3 heparin products_ Oriental Fortune Net

Dongcheng Pharmaceutical: The company is currently developing 3 heparin products

A-share heparin concept change, Qianhong Pharmaceutical rushes to the daily limit, and the industry leader has different performances?

Net worth of Cathay Medical and Health shares fell 3.34% Cathay Pacific_Sina Finance_Sina Network

What are the leading stocks in the pharmaceutical industry?

Want to see more data? Registered subscribers can see all the data.